A New Era in Life Science is Here | April 1, 2022
Submitted by Bayer
What do you get when you combine the best ideas coming out of biology, chemistry and data science?
A powerful tool with the potential to change lives for the better.
From curing incurable diseases, providing people with preventive tools to live healthier, better and longer lives, to producing enough food for our growing population without starving the planet, we are on the brink of unlocking a world of enormous potential.
While the world’s biggest challenges may appear to be very different in nature, the key to overcoming them could be similar. It all comes down to this confluence of the life sciences and data science.
Join us for the Bayer Breakthrough Innovation Forum where we will shed light on the promise this new era in the Life Sciences holds for humanity.
Join us April 1 for a virtual event - Add to calendar
What does this mean for health and nutrition?
While still in its early stages, the convergence of chemistry, biology and data science to accelerate innovation is much more than a theoretical scientific concept. Scientists around the world are already working on applications that leverage today’s enhanced technological toolkit to decode and engineer biology for the benefit of people and the planet.
We are driven to push the limits of what medicine can do today. Cell and gene therapies can move the needle from managing sick care, to providing true healthcare. Precise, personalized care could one day be available to everyone on the planet — before they get sick.
In agriculture, biotechnology will be a critical enabler for our ability to feed the 10 billion people that will be on the planet by 2050 while at the same time fighting the impact of climate change. To grow more food with fewer resources like water, we will need to shift to a regenerative approach and make crops more resilient to climate impacts.
Shorter stature corn, and the number of resources it saves by not snapping in high winds, is just one example of climate-smart agriculture already in action. And advances in digital farming are giving growers the opportunity to maximize the amount of carbon they capture from the atmosphere. Our work to establish the carbon marketplace is one more example of genetics and data coming together to help solve what previously seemed unsolvable.
"Health and nutrition are among the most basic needs of societies around the globe. It’s the definition of systemic relevance. Based on the converging worlds of genes, cells and data, we see a
new foundation for scientific breakthroughs in those areas."
Werner Baumann , Chairman of the Board of Management (CEO) of Bayer AG
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
More from Bayer